Hemoglobin increases mortality from bacterial endotoxin

Infection and Immunity

Volumn 65, Issue 4, 1997, Pages 1258-1266

  Su, Donghui ^a,c   Roth, Robert I ^a,b   Yoshida, Minoru ^a,d   Levin, Jack ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Fujian Medical College   (China)

^d JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE;

ARTICLE; ENDOTOXEMIA; ESCHERICHIA COLI; HEMOGLOBIN ANALYSIS; HYPOTENSION; MORTALITY; PRIORITY JOURNAL; PROTEIN BINDING; RETICULOENDOTHELIAL SYSTEM; SALMONELLA TYPHI; SEPSIS; TRAUMATIC SHOCK;

EID: 0030984960     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.4.1258-1266.1997     Document Type: Article

References (33)

1. Beeson, P. B. 1947. Tolerance to bacterial pyrogens. II. Role of the reticuloendothelial system. J. Exp. Med. 86:39-44.
2. Benacerraf, B., and M. M. Sebestyen. 1957. Effect of bacterial endotoxins on the reticuloendothelial system. Fed. Proc. 16:860-867.
3. Beutler, B., I. W. Milsark, and A. Cerami. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869-871.
4. Bucci, E., A. Razynska, H. Kwansa, H. Matheson-Urbaitis, M. O'Hearn, J. A. Ulatowski, and R. C. Koehler. 1996. Production and characteristics of an infusable oxygen carrying fluid based on hemoglobin intramolecularly crosslinked with sebacic acid. J. Lab. Clin. Med. 128:146-153.
5. 0 for possible use as a blood substitute. J. Biochem. Biophys. Methods 17:145-154.
6. 5a. Committee on Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources, National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, D.C.
7. Crafton, C. G., and N. R. Di Luzio. 1969. Relationship of reticuloendothelial functional activity to endotoxin lethality. Am. J. Physiol. 217:736-742.
8. Eaton, J. W., P. Brandt, and J. R. Mahoney. 1982. Haptoglobin: a natural bacteriostat. Science 215:691-693.
9. Griffiths, E., A. Cortes, N. Gilbert, P. Stevenson, S. MacDonald, and D. Pepper. 1995. Haemoglobin-based blood substitutes and sepsis. Lancet 345: 158-160.
10. Hau, T., and R. L. Simmons. 1980. Mechanisms of the adjuvant effect of hemoglobin in experimental peritonitis. III. The influence of hemoglobin on phagocytosis and intracellular killing by human granulocytes. Surgery 87: 588-592.
11. Hau, T., R. D. Nelson, V. D. Fiegel, R. Levenson, and R. L. Simmons. 1977. Mechanisms of the adjuvant action of hemoglobin in experimental peritonitis. J. Surg. Res. 22:174-180.
12. Kaca, W., R. I. Roth, A. Ziolkowski, and J. Levin. 1994. Human hemoglobin increases the biological activity of bacterial lipopolysaccharides in activation of limulus amebocyte lysate and stimulation of tissue factor production by endothelial cells. J. Endotoxin Res. 1:243-252.
13. Kaca, W., R. I. Roth, and J. Levin. 1994. Hemoglobin: a newly recognized lipopolysaccharide (LPS) binding protein which enhances LPS biological activity. J. Biol. Chem. 269:25078-25084.
14. Kaca, W., R. I. Roth, K. D. Vandegriff, G. C. Chen, F. A. Kuypers, R. M. Winslow, and J. Levin. 1995. Effects of bacterial endotoxin on human crosslinked and native hemoglobins. Biochemistry 34:11176-11185.
15. Kaye, D., and E. W. Hook. 1963. The influence of hemolysis on susceptibility to Salmonella infection: additional observations. J. Immunol. 91: 518-527.
16. Kaye, D., and E. W. Hook. 1963. The influence of hemolysis or blood loss on susceptibility to infections. J. Immunol. 91:65-75.
17. Langermans, J. A. M., and W. K. Bleeker. 1995. Haemoglobin-based blood substitutes and infection. Lancet 345:863-864.
18. Langermans, J. A. M., M. E. B. van Vuren-van der Hulst, and W. K. Bleeker. 1996. Safety evaluation of a polymerized hemoglobin solution in a murine infection model. J. Lab. Clin. Med. 127:428-434.
19. Lee, J. T., D. H. Ahrenholz, R. D. Nelson, and R. L. Simmons. 1979. Mechanisms of the adjuvant effect of hemoglobin in experimental peritonitis. V. The significance of the coordinated iron component. Surgery 86:41-48.
20. Litwin, M. S., C. W. Walter, P. Ejarque, and E. S. Reynolds. 1963. Synergistic toxicity of gram-negative bacteria and free colloidal hemoglobin, Ann. Surg. 157:485-493.
21. Marks, D. H., J. Patressi, and I. H. Chaudry. 1985. Effect of pyridoxalated stabilized stroma-free hemoglobin solution on the clearance of intravascular lipid by the reticuloendothelial system. Circ. Shock 16:165-172.
22. Michie, H. R., K. R. Manogue, D. R. Spriggs, A. Revhaug, S. O'Dwyer, S. M. Wolff, and D. W. Wilmore. 1988. Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 318:1481-1486.
23. Morrison, D. C. 1986. C3H/HeJ mouse strain: role in elucidation of host response to bacterial endotoxins, p. 23-28. In P. Bonventre (ed.). Microbiology. American Society for Microbiology, Washington, D.C.
24. Roth, R. I. 1994. Hemoglobin enhances the production of tissue factor by endothelial cells in response to bacterial endotoxin. Blood 83:2860-2865.
25. Roth, R. I. 1996. Hemoglobin enhances the binding of bacterial endotoxin to human endothelial cells. Thromb. Haemostasis 76:258-262.
26. Roth, R. I., J. Levin, K. W. Chapman, M. Schmeizl, and F. R. Rickles. 1993. Production of modified crosslinked cell-tree hemoglobin for human use: the role of quantitative determination of endotoxin contamination. Transfusion 33:919-924.
27. Stuart, A. E., and G. N. Cooper. 1962. Susceptibility of mice to bacterial endotoxin after modification of reticuloendothelial function by simple lipids. J. Pathol. Bacteriol. 83:245-254.
28. 26a.Su, D., R. I. Roth, and J. Levin. 1995. Hemoglobin enhances the mortality from bacterial endotoxin. Blood 86(Suppl. 1 ):445a.
29. Sultzer, B. M. 1968. Genetic control of leucocyte responses to endotoxin. Nature 219:1253-1254.
30. Tracey, K. J., B. Beutler, S. F. Lowry, J. Merryweather, S. Wolpe, I. W. Milsark, R. J. Hariri, T. J. Fahey III, A. Zenttella, J. D. Albert, G. T. Shires, and , A. Cerami. 1986. Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474.
31. 2 transport with hematocrit reduced by cross-linked hemoglobin transfusion. Am. J. Physiol. 270(Heart Circ. Physiol. 39):H466-H475.
32. White, C. T., A. J. Murray, D. J. Smith, J. R. Greene, and R. B. Bolin. 1986. Synergistic toxicity of endotoxin and hemoglobin. J. Lab. Clin. Med. 108: 132-137.
33. Winslow, R. M., and K. W. Chapman. 1994. Pilot-scale preparation of hemoglobin solutions. Methods Enzymol. 231:3-16.